2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Journal of the American College of Cardiology

Volumn 67, Issue 13, 2016, Pages 1575-1623

  Page, Richard L ^a   Joglar, José A ^a   Caldwell, Mary A ^a   Calkins, Hugh ^a   Conti, Jamie B ^a   Deal, Barbara J ^a   Estes, N A Mark ^a   Field, Michael E ^a   Goldberger, Zachary D ^a   Hammill, Stephen C ^a   Indik, Julia H ^a   Lindsay, Bruce D ^a   Olshansky, Brian ^a   Russo, Andrea M ^a   Shen, Win Kuang ^a   Tracy, Cynthia M ^a   Al Khatib, Sana M ^a  

^a NONE

Author keywords

ACC AHA Clinical Practice Guidelines; accessory atrioventricular bundle; anti arrhythmia agents; atrial flutter; atrioventricular nodal reentry; cardiac; catheter ablation; congenital; death; ectopic atrial; ectopic junctional; electric countershock; electrophysiologic techniques; heart defects; reciprocating; sinus tachycardia; sudden; supraventricular; tachycardia; Valsalva maneuver; Wolff Parkinson White syndrome

Indexed keywords

ADENOSINE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; FLECAINIDE; IBUTILIDE; IVABRADINE; METOPROLOL; PROPAFENONE; SOTALOL; THEOPHYLLINE; VERAPAMIL;

ADULT; ADULT CONGENITAL HEART DISEASE; ARTICLE; ASYMPTOMATIC PRE EXCITATION; ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CAVOTRICUSPID ISTHMUS DEPENDENT ATRIAL FLUTTER; COMORBIDITY; CONGENITAL HEART DISEASE; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; FOCAL ATRIAL TACHYCARDIA; HEALTH CARE CONCEPTS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEART ACCESSORY CONDUCTION PATHWAY; HEART ATRIUM FLUTTER; HEART PREEXCITATION; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; MEDICAL CARE; METHODOLOGY; MULTIFOCAL ATRIAL TACHYCARDIA; NON ISTHMUS DEPENDENT ATRIAL FLUTTER; NONSINUS FOCAL ATRIAL TACHYCARDIA; PEDIATRICS; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH IMPACT; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SHARED DECISION MAKING; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; CARDIOLOGY; CLASSIFICATION; EVIDENCE BASED PRACTICE; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PROCEDURES; STANDARDS; UNITED STATES;

ADULT; AMERICAN HEART ASSOCIATION; CARDIOLOGY; EVIDENCE-BASED PRACTICE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TACHYCARDIA, SUPRAVENTRICULAR; UNITED STATES;

EID: 85027228129     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.019     Document Type: Article

References (397)

1. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.). Clinical Practice Guidelines We Can Trust. 2011, National Academies Press, Washington, DC.
2. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.). Finding What Works in Health Care: Standards for Systematic Reviews. 2011, National Academies Press, Washington, DC.
3. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Available at: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf and http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm_319826.pdf. Accessed January 23, 2015.
4. Jacobs, A.K., Kushner, F.G., Ettinger, S.M., et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), 213–265.
5. Jacobs, A.K., Anderson, J.L., Halperin, J.L., The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (2014), 1373–1384.
6. Anderson, J.L., Heidenreich, P.A., Barnett, P.G., et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2304–2322.
7. Halperin, J.L., Levine, G.N., Al-Khatib, S.M., Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 67 (2016), 1572–1574.
8. Arnett, D.K., Goodman, R.A., Halperin, J.L., et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. J Am Coll Cardiol 64 (2014), 1851–1856.
9. Page, R.L., Joglar, J.A., Al-Khatib, S.M., et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 67 (2016), 1575–1623.
10. Al-Khatib, S.M., Arshad, A., Balk, E.M., et al. Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 67 (2016), 1617–1629.
11. January, C.T., Wann, L.S., Alpert, J.S., et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64 (2014), 2246–2280.
12. Blomström-Lundqvist, C., Scheinman, M.M., Aliot, E.M., et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 42 (2003), 1493–1531.
13. Orejarena, L.A., Vidaillet, H., DeStefano, F., et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 31 (1998), 150–157.
14. Lu, C.-W., Wu, M.-H., Chen, H.-C., et al. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol 174 (2014), 530–534.
15. Whinnett, Z.I., Sohaib, S.M.A., Davies, D.W., Diagnosis and management of supraventricular tachycardia. BMJ, 345, 2012, e7769.
16. Porter, M.J., Morton, J.B., Denman, R., et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 1 (2004), 393–396.
17. Goyal, R., Zivin, A., Souza, J., et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 132 (1996), 765–767.
18. Maryniak, A., Bielawska, A., Bieganowska, K., et al. Does atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) in children affect their cognitive and emotional development?. Pediatr Cardiol 34 (2013), 893–897.
19. González-Torrecilla, E., Almendral, J., Arenal, A., et al. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol 53 (2009), 2353–2358.
20. Liu, S., Yuan, S., Hertervig, E., et al. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 34 (2001), 295–301.
21. Anand, R.G., Rosenthal, G.L., Van Hare, G.F., et al. Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity?. Congenit Heart Dis 4 (2009), 464–468.
22. Walfridsson, U., Strömberg, A., Janzon, M., et al. Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life. Pacing Clin Electrophysiol 32 (2009), 1299–1306.
23. Cain, N., Irving, C., Webber, S., et al. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 112 (2013), 961–965.
24. Laurent, G., Leong-Poi, H., Mangat, I., et al. Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia. J Cardiovasc Electrophysiol 20 (2009), 176–181.
25. Auricchio, A., Klein, H., Trappe, H.J., et al. Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 17 (1991), 152–158.
26. Drago, F., Turchetta, A., Calzolari, A., et al. Reciprocating supraventricular tachycardia in children: low rate at rest as a major factor related to propensity to syncope during exercise. Am Heart J 132 (1996), 280–285.
27. Kalusche, D., Ott, P., Arentz, T., et al. AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy. Coron Artery Dis 9 (1998), 359–363.
28. Haghjoo, M., Arya, A., Heidari, A., et al. Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderly patients with atrioventricular nodal reentrant tachycardia. J Electrocardiol 40 (2007), 208–213.
29. Walfridsson, U., Walfridsson, H., The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation. Pacing Clin Electrophysiol 28 (2005), 191–195.
30. Letsas, K.P., Weber, R., Siklody, C.H., et al. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway. Acta Cardiol 65 (2010), 171–176.
31. Knight, B.P., Ebinger, M., Oral, H., et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 36 (2000), 574–582.
32. Murman, D.H., McDonald, A.J., Pelletier, A.J., et al. U.S. emergency department visits for supraventricular tachycardia, 1993-2003. Acad Emerg Med 14 (2007), 578–581.
33. Lim, S.H., Anantharaman, V., Teo, W.S., et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 31 (1998), 30–35.
34. Luber, S., Brady, W.J., Joyce, T., et al. Paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med 19 (2001), 40–42.
35. Waxman, M.B., Wald, R.W., Sharma, A.D., et al. Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol 46 (1980), 655–664.
36. Brady, W.J., DeBehnke, D.J., Wickman, L.L., et al. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med 3 (1996), 574–585.
37. Cairns, C.B., Niemann, J.T., Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med 20 (1991), 717–721.
38. Gausche, M., Persse, D.E., Sugarman, T., et al. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med 24 (1994), 183–189.
39. Madsen, C.D., Pointer, J.E., Lynch, T.G., A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Ann Emerg Med 25 (1995), 649–655.
40. McCabe, J.L., Adhar, G.C., Menegazzi, J.J., et al. Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med 21 (1992), 358–361.
41. Rankin, A.C., Oldroyd, K.G., Chong, E., et al. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 62 (1989), 195–203.
42. Lim, S.H., Anantharaman, V., Teo, W.S., et al. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 80 (2009), 523–528.
43. DiMarco, J.P., Miles, W., Akhtar, M., et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med 113 (1990), 104–110.
44. Roth, A., Elkayam, I., Shapira, I., et al. Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol 91 (2003), 489–491.
45. Stec, S., Kryñski, T., Kułakowski, P., Efficacy of low energy rectilinear biphasic cardioversion for regular atrial tachyarrhythmias. Cardiol J 18 (2011), 33–38.
46. Lim, S.H., Anantharaman, V., Teo, W.S., Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia. Resuscitation 52 (2002), 167–174.
47. Gupta, A., Naik, A., Vora, A., et al. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Physicians India 47 (1999), 969–972.
48. Dorian, P., Naccarelli, G.V., Coumel, P., et al. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Am J Cardiol 77 (1996), 89A–95A.
49. Mauritson, D.R., Winniford, M.D., Walker, W.S., et al. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial. Ann Intern Med 96 (1982), 409–412.
50. Winniford, M.D., Fulton, K.L., Hillis, L.D., Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 54 (1984), 1138–1139.
51. Jackman, W.M., Beckman, K.J., McClelland, J.H., et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327 (1992), 313–318.
52. Hindricks, G., The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 14 (1993), 1644–1653.
53. Hindricks, G., Incidence of complete atrioventricular block following attempted radiofrequency catheter modification of the atrioventricular node in 880 patients. Results of the Multicenter European Radiofrequency Survey (MERFS) The Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 17 (1996), 82–88.
54. Spector, P., Reynolds, M.R., Calkins, H., et al. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 104 (2009), 671–677.
55. Calkins, H., Yong, P., Miller, J.M., et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99 (1999), 262–270.
56. Scheinman, M.M., Huang, S., The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 23 (2000), 1020–1028.
57. Cheng, C.H., Sanders, G.D., Hlatky, M.A., et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 133 (2000), 864–876.
58. Bohnen, M., Stevenson, W.G., Tedrow, U.B., et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm 8 (2011), 1661–1666.
59. Tendera, M., Wnuk-Wojnar, A.M., Kulakowski, P., et al. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J 142 (2001), 93–98.
60. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation 92 (1995), 2550–2557.
61. Chimienti, M., Cullen, M.T., Casadei, G., Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Eur Heart J 16 (1995), 1943–1951.
62. Anderson, J.L., Platt, M.L., Guarnieri, T., et al. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol 74 (1994), 578–584.
63. Pritchett, E.L., DaTorre, S.D., Platt, M.L., et al. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. J Am Coll Cardiol 17 (1991), 297–303.
64. Pritchett, E.L., McCarthy, E.A., Wilkinson, W.E., Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 114 (1991), 539–544.
65. Henthorn, R.W., Waldo, A.L., Anderson, J.L., et al. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation 83 (1991), 119–125.
66. Wanless, R.S., Anderson, K., Joy, M., et al. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J 133 (1997), 441–446.
67. Gambhir, D.S., Bhargava, M., Nair, M., et al. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Indian Heart J 48 (1996), 133–137.
68. Haines, D.E., Beheiry, S., Akar, J.G., et al. Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 11 (2014), e9–e51.
69. Knight, B.P., Zivin, A., Souza, J., et al. A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol 33 (1999), 775–781.
70. Horowitz, L.N., Kay, H.R., Kutalek, S.P., et al. Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. J Am Coll Cardiol 9 (1987), 1261–1268.
71. Asirvatham, S., Narayan, O., Advanced catheter mapping and navigation system. Huang, S.W., Wood, M., (eds.) Catheter Ablation of Cardiac Arrhythmias, 2006, Saunders/Elsevier, Philadelphia, PA, 135–161.
72. Sporton, S.C., Earley, M.J., Nathan, A.W., et al. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol 15 (2004), 310–315.
73. Alvarez, M., Tercedor, L., Almansa, I., et al. Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance. Heart Rhythm 6 (2009), 1714–1720.
74. Casella, M., Pelargonio, G., Dello, R.A., et al. “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX mapping system: personal experience and review of the literature. J Interv Card Electrophysiol 31 (2011), 109–118.
75. Razminia, M., Manankil, M.F., Eryazici, P.L.S., et al. Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy. J Cardiovasc Electrophysiol 23 (2012), 1078–1086.
76. Earley, M.J., Showkathali, R., Alzetani, M., et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 27 (2006), 1223–1229.
77. Hindricks, G., Willems, S., Kautzner, J., et al. Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study. J Cardiovasc Electrophysiol 20 (2009), 734–740.
78. Xu, D., Yang, B., Shan, Q., et al. Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias. J Interv Card Electrophysiol 25 (2009), 171–174.
79. Sommer, P., Wojdyla-Hordynska, A., Rolf, S., et al. Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. Europace 15 (2013), 578–581.
80. Cummings, J.E., Pacifico, A., Drago, J.L., et al. Alternative energy sources for the ablation of arrhythmias. Pacing Clin Electrophysiol 28 (2005), 434–443.
81. Olshansky, B., Sullivan, R.M., Inappropriate sinus tachycardia. J Am Coll Cardiol 61 (2013), 793–801.
82. Marcus, B., Gillette, P.C., Garson, A., Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control. Am Heart J 119 (1990), 911–916.
83. Jose, A.D., Collison, D., The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 4 (1970), 160–167.
84. Alboni, P., Malcarne, C., Pedroni, P., et al. Electrophysiology of normal sinus node with and without autonomic blockade. Circulation 65 (1982), 1236–1242.
85. Cappato, R., Castelvecchio, S., Ricci, C., et al. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J Am Coll Cardiol 60 (2012), 1323–1329.
86. Benezet-Mazuecos, J., Rubio, J.M., Farré, J., et al. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol 36 (2013), 830–836.
87. Ptaszynski, P., Kaczmarek, K., Ruta, J., et al. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace 15 (2013), 116–121.
88. Ptaszynski, P., Kaczmarek, K., Ruta, J., et al. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol 36 (2013), 42–49.
89. Ptaszynski, P., Kaczmarek, K., Ruta, J., et al. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther 18 (2013), 338–344.
90. Calò, L., Rebecchi, M., Sette, A., et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 7 (2010), 1318–1323.
91. Kaplinsky, E., Comes, F.P., Urondo, L.S.V., et al. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Cardiol J 17 (2010), 166–171.
92. Rakovec, P., Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr 121 (2009), 715–718.
93. Zellerhoff, S., Hinterseer, M., Felix Krull, B., et al. Ivabradine in patients with inappropriate sinus tachycardia. Naunyn Schmiedebergs Arch Pharmacol 382 (2010), 483–486.
94. Man, K.C., Knight, B., Tse, H.F., et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 35 (2000), 451–457.
95. Lin, D., Garcia, F., Jacobson, J., et al. Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia. Pacing Clin Electrophysiol 30 (2007), 236–242.
96. Lee, R.J., Kalman, J.M., Fitzpatrick, A.P., et al. Radiofrequency catheter modification of the sinus node for “inappropriate” sinus tachycardia. Circulation 92 (1995), 2919–2928.
97. Marrouche, N.F., Beheiry, S., Tomassoni, G., et al. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol 39 (2002), 1046–1054.
98. Callans, D.J., Ren, J.F., Schwartzman, D., et al. Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography. J Am Coll Cardiol 33 (1999), 1667–1670.
99. Frankel, D.S., Lin, D., Anastasio, N., et al. Frequent additional tachyarrhythmias in patients with inappropriate sinus tachycardia undergoing sinus node modification: an important cause of symptom recurrence. J Cardiovasc Electrophysiol 23 (2012), 835–839.
100. Takemoto, M., Mukai, Y., Inoue, S., et al. Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and long-term clinical outcome. Intern Med 51 (2012), 357–362.
101. Klein, I., Ojamaa, K., Thyroid hormone and the cardiovascular system. N Engl J Med 344 (2001), 501–509.
102. Steinbeck, G., Hoffmann, E., ‘True’ atrial tachycardia. Eur Heart J 19:Suppl E (1998), E48–E49.
103. Wren, C., Incessant tachycardias. Eur Heart J 19:Suppl E (1998), E54–E59.
104. Medi, C., Kalman, J.M., Haqqani, H., et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 53 (2009), 1791–1797.
105. Tang, C.W., Scheinman, M.M., Van Hare, G.F., et al. Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol 26 (1995), 1315–1324.
106. Kistler, P.M., Roberts-Thomson, K.C., Haqqani, H.M., et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 48 (2006), 1010–1017.
107. Chen, S.A., Chiang, C.E., Yang, C.J., et al. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 90 (1994), 1262–1278.
108. Kalman, J.M., Olgin, J.E., Karch, M.R., et al. “Cristal tachycardias”: origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol 31 (1998), 451–459.
109. Morton, J.B., Sanders, P., Das, A., et al. Focal atrial tachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics. J Cardiovasc Electrophysiol 12 (2001), 653–659.
110. Kistler, P.M., Sanders, P., Fynn, S.P., et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation 108 (2003), 1968–1975.
111. Kistler, P.M., Sanders, P., Hussin, A., et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol 41 (2003), 2212–2219.
112. Gonzalez, M.D., Contreras, L.J., Jongbloed, M.R.M., et al. Left atrial tachycardia originating from the mitral annulus-aorta junction. Circulation 110 (2004), 3187–3192.
113. Kistler, P.M., Fynn, S.P., Haqqani, H., et al. Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Am Coll Cardiol 45 (2005), 1488–1493.
114. Ouyang, F., Ma, J., Ho, S.Y., et al. Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation. J Am Coll Cardiol 48 (2006), 122–131.
115. Roberts-Thomson, K.C., Kistler, P.M., Haqqani, H.M., et al. Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol 18 (2007), 367–372.
116. Biviano, A.B., Bain, W., Whang, W., et al. Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics. Pacing Clin Electrophysiol 35 (2012), 17–27.
117. Walters, T.E., Kistler, P.M., Kalman, J.M., Radiofrequency ablation for atrial tachycardia and atrial flutter. Heart Lung Circ 21 (2012), 386–394.
118. Lee, G., Sanders, P., Kalman, J.M., Catheter ablation of atrial arrhythmias: state of the art. Lancet 380 (2012), 1509–1519.
119. Gillette, P.C., Garson, A. Jr., Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia. Circulation 56 (1977), 571–575.
120. Mehta, A.V., Sanchez, G.R., Sacks, E.J., et al. Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol 11 (1988), 379–385.
121. Markowitz, S.M., Stein, K.M., Mittal, S., et al. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 10 (1999), 489–502.
122. Reisinger, J., Gstrein, C., Winter, T., et al. Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med 28 (2010), 159–165.
123. Engelstein, E.D., Lippman, N., Stein, K.M., et al. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation 89 (1994), 2645–2654.
124. Eidher, U., Freihoff, F., Kaltenbrunner, W., et al. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol 29 (2006), 358–362.
125. de Loma-Osorio, F., Diaz-Infante, E., et al. Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012). Rev Esp Cardiol (Engl Ed) 66 (2013), 983–992.
126. Liu, X., Dong, J., Ho, S.Y., et al. Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights. J Am Coll Cardiol 56 (2010), 796–804.
127. Creamer, J.E., Nathan, A.W., Camm, A.J., Successful treatment of atrial tachycardias with flecainide acetate. Br Heart J 53 (1985), 164–166.
128. Kunze, K.P., Kuck, K.H., Schlüter, M., et al. Effect of encainide and flecainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol 7 (1986), 1121–1126.
129. von Bernuth, G., Engelhardt, W., Kramer, H.H., et al. Atrial automatic tachycardia in infancy and childhood. Eur Heart J 13 (1992), 1410–1415.
130. Lucet, V., Do Ngoc, D., Fidelle, J., et al. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases]. Arch Mal Coeur Vaiss 80 (1987), 1385–1393.
131. Heusch, A., Kramer, H.H., Krogmann, O.N., et al. Clinical experience with propafenone for cardiac arrhythmias in the young. Eur Heart J 15 (1994), 1050–1056.
132. Colloridi, V., Perri, C., Ventriglia, F., et al. Oral sotalol in pediatric atrial ectopic tachycardia. Am Heart J 123 (1992), 254–256.
133. Guccione, P., Paul, T., Garson, A. Jr., Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 15 (1990), 1118–1124.
134. Coumel, P., Fidelle, J., Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 100 (1980), 1063–1069.
135. Miyazaki, A., Ohuchi, H., Kurosaki, K., et al. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 72 (2008), 1998–2003.
136. Kang, K.T., Etheridge, S.P., Kantoch, M.J., et al. Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol 7 (2014), 664–670.
137. Wang, K., Goldfarb, B.L., Gobel, F.L., et al. Multifocal atrial tachycardia. Arch Intern Med 137 (1977), 161–164.
138. Bittar, G., Friedman, H.S., The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 99 (1991), 1415–1420.
139. Iseri, L.T., Fairshter, R.D., Hardemann, J.L., et al. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 110 (1985), 789–794.
140. Kastor, J.A., Multifocal atrial tachycardia. N Engl J Med 322 (1990), 1713–1717.
141. Arsura, E.L., Solar, M., Lefkin, A.S., et al. Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med 15 (1987), 591–594.
142. Levine, J.H., Michael, J.R., Guarnieri, T., Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 312 (1985), 21–25.
143. Salerno, D.M., Anderson, B., Sharkey, P.J., et al. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 107 (1987), 623–628.
144. Hazard, P.B., Burnett, C.R., Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. Chest 91 (1987), 68–70.
145. Hazard, P.B., Burnett, C.R., Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med 15 (1987), 20–25.
146. Mehta, D., Wafa, S., Ward, D.E., et al. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet 1 (1988), 1181–1185.
147. Wen, Z.C., Chen, S.A., Tai, C.T., et al. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 98 (1998), 2716–2723.
148. Glatter, K.A., Cheng, J., Dorostkar, P., et al. Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation 99 (1999), 1034–1040.
149. Dougherty, A.H., Jackman, W.M., Naccarelli, G.V., et al. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Am J Cardiol 70 (1992), 587–592.
150. Waxman, H.L., Myerburg, R.J., Appel, R., et al. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med 94 (1981), 1–6.
151. Amsterdam, E.A., Kulcyski, J., Ridgeway, M.G., Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. J Clin Pharmacol 31 (1991), 714–718.
152. Das, G., Tschida, V., Gray, R., et al. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. J Clin Pharmacol 28 (1988), 746–750.
153. Alboni, P., Tomasi, C., Menozzi, C., et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 37 (2001), 548–553.
154. Yeh, S.J., Lin, F.C., Chou, Y.Y., et al. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol. Circulation 71 (1985), 104–109.
155. Rinkenberger, R.L., Prystowsky, E.N., Heger, J.J., et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 62 (1980), 996–1010.
156. D'Este, D., Zoppo, F., Bertaglia, E., et al. Long-term outcome of patients with atrioventricular node reentrant tachycardia. Int J Cardiol 115 (2007), 350–353.
157. Langberg, J.J., Leon, A., Borganelli, M., et al. A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia. Circulation 87 (1993), 1551–1556.
158. Kalbfleisch, S.J., Strickberger, S.A., Williamson, B., et al. Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 23 (1994), 716–723.
159. Kay, G.N., Epstein, A.E., Dailey, S.M., et al. Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation 85 (1992), 1675–1688.
160. Bogun, F., Knight, B., Weiss, R., et al. Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia. J Am Coll Cardiol 28 (1996), 1000–1004.
161. O'Hara, G.E., Philippon, F., Champagne, J., et al. Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital. Can J Cardiol 23:Suppl B (2007), 67B–70B.
162. Gambhir, D.S., Bhargava, M., Arora, R., et al. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Indian Heart J 47 (1995), 237–243.
163. Musto, B., Cavallaro, C., Musto, A., et al. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J 124 (1992), 110–115.
164. Munger, T.M., Packer, D.L., Hammill, S.C., et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 87 (1993), 866–873.
165. Pappone, C., Vicedomini, G., Manguso, F., et al. Wolff-Parkinson-white syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation 130 (2014), 811–819.
166. Timmermans, C., Smeets, J.L., Rodriguez, L.M., et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 76 (1995), 492–494.
167. Klein, G.J., Bashore, T.M., Sellers, T.D., et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301 (1979), 1080–1085.
168. Bromberg, B.I., Lindsay, B.D., Cain, M.E., et al. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 27 (1996), 690–695.
169. Santinelli, V., Radinovic, A., Manguso, F., et al. The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 53 (2009), 275–280.
170. Neumar, R.W., Otto, C.W., Link, M.S., et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122 (2010), S729–S767.
171. Smith, G.D., Dyson, K., Taylor, D., et al. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev, 3, 2013, CD009502.
172. Delaney, B., Loy, J., Kelly, A.-M., The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med 18 (2011), 148–152.
173. Furlong, R., Gerhardt, R.T., Farber, P., et al. Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control. Am J Emerg Med 13 (1995), 383–388.
174. Schatz, I., Ordog, G.J., Karody, R., et al. Wolff-Parkinson-White syndrome presenting in atrial fibrillation. Ann Emerg Med 16 (1987), 574–578.
175. Mittal, S., Ayati, S., Stein, K.M., et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101 (2000), 1282–1287.
176. Glatter, K.A., Dorostkar, P.C., Yang, Y., et al. Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation 104 (2001), 1933–1939.
177. Sellers, T.D. Jr., Campbell, R.W., Bashore, T.M., et al. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation 55 (1977), 15–22.
178. Huycke, E.C., Sung, R.J., Dias, V.C., et al. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study. J Am Coll Cardiol 13 (1989), 538–544.
179. Hamer, A., Peter, T., Platt, M., et al. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome. Am Heart J 101 (1981), 600–612.
180. Hombach, V., Braun, V., Hopp, H.W., et al. Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise. Klin Wochenschr 59 (1981), 123–133.
181. Morady, F., DiCarlo, L.A. Jr., Baerman, J.M., et al. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 10 (1987), 492–496.
182. Sellers, T.D. Jr., Bashore, T.M., Gallagher, J.J., Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation. Circulation 56 (1977), 260–267.
183. Sheinman, B.D., Evans, T., Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome. Br Med J (Clin Res Ed) 285 (1982), 999–1000.
184. Boriani, G., Biffi, M., Frabetti, L., et al. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 131 (1996), 1214–1216.
185. Shiraishi, H., Ishibashi, K., Urao, N., et al. Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia. Intern Med 41 (2002), 445–448.
186. Schützenberger, W., Leisch, F., Gmeiner, R., Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. Int J Cardiol 16 (1987), 93–95.
187. Jackman, W.M., Wang, X.Z., Friday, K.J., et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 324 (1991), 1605–1611.
188. Calkins, H., Langberg, J., Sousa, J., et al. Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation 85 (1992), 1337–1346.
189. Dagres, N., Clague, J.R., Kottkamp, H., et al. Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up. Eur Heart J 20 (1999), 1826–1832.
190. Schläpfer, J., Fromer, M., Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways. Eur Heart J 22 (2001), 605–609.
191. Belhassen, B., Rogowski, O., Glick, A., et al. Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients. Isr Med Assoc J 9 (2007), 265–270.
192. Kugler, J.D., Danford, D.A., Deal, B.J., et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 330 (1994), 1481–1487.
193. Kugler, J.D., Danford, D.A., Houston, K., et al. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 80 (1997), 1438–1443.
194. Sakurai, M., Yasuda, H., Kato, N., et al. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Am Heart J 105 (1983), 619–628.
195. Hopson, J.R., Buxton, A.E., Rinkenberger, R.L., et al. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol 77 (1996), 72A–82A.
196. Feld, G.K., Nademanee, K., Weiss, J., et al. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. J Am Coll Cardiol 3 (1984), 1298–1307.
197. Feld, G.K., Nademanee, K., Stevenson, W., et al. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Am Heart J 115 (1988), 102–107.
198. Bauernfeind, R.A., Wyndham, C.R., Dhingra, R.C., et al. Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia. Circulation 62 (1980), 1341–1349.
199. Sharma, A.D., Yee, R., Guiraudon, G., et al. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 10 (1987), 373–381.
200. Gaita, F., Giustetto, C., Riccardi, R., et al. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol 64 (1989), 487–490.
201. Spar, D.S., Silver, E.S., Hordof, A.J., et al. Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location. Am J Cardiol 109 (2012), 1011–1014.
202. Wackel, P., Irving, C., Webber, S., et al. Risk stratification in Wolff-Parkinson-White syndrome: the correlation between noninvasive and invasive testing in pediatric patients. Pacing Clin Electrophysiol 35 (2012), 1451–1457.
203. Beckman, K.J., Gallastegui, J.L., Bauman, J.L., et al. The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 15 (1990), 640–647.
204. Pappone, C., Vicedomini, G., Manguso, F., et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation 125 (2012), 661–668.
205. Rinne, C., Klein, G.J., Sharma, A.D., et al. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol 60 (1987), 576–579.
206. Brembilla-Perrot, B., Holban, I., Houriez, P., et al. Influence of age on the potential risk of sudden death in asymptomatic Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 24 (2001), 1514–1518.
207. Pappone, C., Santinelli, V., Manguso, F., et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349 (2003), 1803–1811.
208. Pappone, C., Santinelli, V., Rosanio, S., et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41 (2003), 239–244.
209. Epstein, A.E., Miles, W.M., Benditt, D.G., et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 94 (1996), 1147–1166.
210. Klein, G.J., Yee, R., Sharma, A.D., Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med 320 (1989), 1229–1233.
211. Leitch, J.W., Klein, G.J., Yee, R., et al. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation 82 (1990), 1718–1723.
212. Milstein, S., Sharma, A.D., Klein, G.J., Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Am J Cardiol 57 (1986), 1097–1100.
213. Satoh, M., Aizawa, Y., Funazaki, T., et al. Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern. Pacing Clin Electrophysiol 12 (1989), 413–420.
214. Havránek, S., Simek, J., St'ovíček, P., et al. Distribution of mean cycle length in cavo-tricuspid isthmus dependent atrial flutter. Physiol Res 61 (2012), 43–51.
215. Waldo, A.L., Feld, G.K., Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol 51 (2008), 779–786.
216. Pérez, F.J., Schubert, C.M., Parvez, B., et al. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol 2 (2009), 393–401.
217. Ellis, K., Wazni, O., Marrouche, N., et al. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol 18 (2007), 799–802.
218. Hsieh, M.-H., Tai, C.-T., Chiang, C.-E., et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J Interv Card Electrophysiol 7 (2002), 225–231.
219. Tai, C.T., Chen, S.A., Chiang, C.E., et al. Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 9 (1998), 115–121.
220. Paydak, H., Kall, J.G., Burke, M.C., et al. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation 98 (1998), 315–322.
221. Chinitz, J.S., Gerstenfeld, E.P., Marchlinski, F.E., et al. Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 4 (2007), 1029–1033.
222. Teh, A.W., Medi, C., Lee, G., et al. Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol 34 (2011), 431–435.
223. Gerstenfeld, E.P., Callans, D.J., Dixit, S., et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 110 (2004), 1351–1357.
224. Chugh, A., Oral, H., Lemola, K., et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm 2 (2005), 464–471.
225. Veenhuyzen, G.D., Knecht, S., O'Neill, M.D., et al. Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management. Pacing Clin Electrophysiol 32 (2009), 393–398.
226. Karch, M.R., Zrenner, B., Deisenhofer, I., et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111 (2005), 2875–2880.
227. Sawhney, N., Anousheh, R., Chen, W., et al. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 3 (2010), 243–248.
228. Neumann, T., Vogt, J., Schumacher, B., et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 52 (2008), 273–278.
229. Ellenbogen, K.A., Stambler, B.S., Wood, M.A., et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 28 (1996), 130–136.
230. Suttorp, M.J., Kingma, J.H., Jessurun, E.R., et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 16 (1990), 1722–1727.
231. Stambler, B.S., Wood, M.A., Ellenbogen, K.A., et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 94 (1996), 1613–1621.
232. Kingma, J.H., Suttorp, M.J., Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am J Cardiol 70 (1992), 56A–60A.
233. Vos, M.A., Golitsyn, S.R., Stangl, K., et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 79 (1998), 568–575.
234. Volgman, A.S., Carberry, P.A., Stambler, B., et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 31 (1998), 1414–1419.
235. Steinwender, C., Hönig, S., Kypta, A., et al. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. Int J Cardiol 141 (2010), 260–265.
236. Singh, S., Zoble, R.G., Yellen, L., et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102 (2000), 2385–2390.
237. Blackshear, J.L., Stambler, B.S., Strauss, W.E., et al. Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter. Am J Cardiol 78 (1996), 1246–1250.
238. Singh, B.N., Hecht, H.S., Nademanee, K., et al. Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog Cardiovasc Dis 25 (1982), 103–132.
239. Akhtar, M., Tchou, P., Jazayeri, M., Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. Circulation 80 (1989), IV31–IV39.
240. Delle Karth, G., Geppert, A., Neunteufl, T., et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29 (2001), 1149–1153.
241. Ellenbogen, K.A., Dias, V.C., Plumb, V.J., et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol 18 (1991), 891–897.
242. Ellenbogen, K.A., Dias, V.C., Cardello, F.P., et al. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. Am J Cardiol 75 (1995), 45–49.
243. Platia, E.V., Michelson, E.L., Porterfield, J.K., et al. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 63 (1989), 925–929.
244. Salerno, D.M., Dias, V.C., Kleiger, R.E., et al. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group. Am J Cardiol 63 (1989), 1046–1051.
245. Gallagher, M.M., Guo, X.H., Poloniecki, J.D., et al. Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol 38 (2001), 1498–1504.
246. Botkin, S.B., Dhanekula, L.S., Olshansky, B., Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 145 (2003), 233–238.
247. Pizzale, S., Lemery, R., Green, M.S., et al. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol 25 (2009), 469–472.
248. Van Gelder, I.C., Crijns, H.J., Van Gilst, W.H., et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68 (1991), 41–46.
249. Boriani, G., Tukkie, R., Manolis, A.S., et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 35 (2014), 2352–2362.
250. Mitchell, A.R.J., Spurrell, P.A.R., Cheatle, L., et al. Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs. Heart 87 (2002), 433–437.
251. Gillis, A.M., Unterberg-Buchwald, C., Schmidinger, H., et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 40 (2002), 1653–1659.
252. Waldo, A.L., MacLean, W.A., Cooper, T.B., et al. Use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open-heart surgery. J Thorac Cardiovasc Surg 76 (1978), 500–505.
253. Peters, R.W., Shorofsky, S.R., Pelini, M., et al. Overdrive atrial pacing for conversion of atrial flutter: comparison of postoperative with nonpostoperative patients. Am Heart J 137 (1999), 100–103.
254. Ghali, W.A., Wasil, B.I., Brant, R., et al. Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis. Am J Med 118 (2005), 101–107.
255. Clemo, H.F., Wood, M.A., Gilligan, D.M., et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 81 (1998), 594–598.
256. Roberts, S.A., Diaz, C., Nolan, P.E., et al. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol 72 (1993), 567–573.
257. Natale, A., Newby, K.H., Pisanó, E., et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 35 (2000), 1898–1904.
258. Bastani, H., Drca, N., Insulander, P., et al. Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison. Europace 15 (2013), 420–428.
259. Poty, H., Saoudi, N., Nair, M., et al. Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation 94 (1996), 3204–3213.
260. Schwartzman, D., Callans, D.J., Gottlieb, C.D., et al. Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol 28 (1996), 1519–1531.
261. Delacretaz, E., Ganz, L.I., Soejima, K., et al. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol 37 (2001), 1665–1676.
262. Jaïs, P., Shah, D.C., Haïssaguerre, M., et al. Mapping and ablation of left atrial flutters. Circulation 101 (2000), 2928–2934.
263. Da Costa, A., Thevenin, J., Roche, F., et al. Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 114 (2006), 1676–1681.
264. Pedersen, O.D., Bagger, H., Keller, N., et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 104 (2001), 292–296.
265. Benditt, D.G., Williams, J.H., Jin, J., et al. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol 84 (1999), 270–277.
266. Reithmann, C., Hoffmann, E., Spitzlberger, G., et al. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 21 (2000), 565–572.
267. Huang, D.T., Monahan, K.M., Zimetbaum, P., et al. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 9 (1998), 462–469.
268. Schumacher, B., Jung, W., Lewalter, T., et al. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 83 (1999), 710–713.
269. Mohanty, S., Mohanty, P., Di Biase, L., et al. Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation 127 (2013), 1853–1860.
270. Wazni, O., Marrouche, N.F., Martin, D.O., et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 108 (2003), 2479–2483.
271. Coffey, J.O., d'Avila, A., Dukkipati, S., et al. Catheter ablation of scar-related atypical atrial flutter. Europace 15 (2013), 414–419.
272. Aliot, E., Denjoy, I., Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group. Am J Cardiol 77 (1996), 66A–71A.
273. Van Gelder, I.C., Crijns, H.J., Van Gilst, W.H., et al. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 64 (1989), 1317–1321.
274. Pietersen, A.H., Hellemann, H., Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 67 (1991), 713–717.
275. Ruder, M.A., Davis, J.C., Eldar, M., et al. Clinical and electrophysiologic characterization of automatic junctional tachycardia in adults. Circulation 73 (1986), 930–937.
276. Wyndham, C.R., Dhingra, R.C., Smith, T., et al. Concealed nonparoxysmal junctional tachycardia. Circulation 60 (1979), 707–710.
277. Konecke, L.L., Knoebel, S.B., Nonparoxysmal junctional tachycardia complicating acute myocardial infarction. Circulation 45 (1972), 367–374.
278. Fishenfeld, J., Desser, K.B., Benchimol, A., Non-paroxysmal A-V junctional tachycardia associated with acute myocardial infarction. Am Heart J 86 (1973), 754–758.
279. Kumagai, K., Yamato, H., Yamanouchi, Y., et al. Automatic junctional tachycardia in an adult. Clin Cardiol 13 (1990), 813–816.
280. Cook, J.R., Steinberg, J.S., An incessant form of junctional ectopic tachycardia in an adult responsive to a class 1C agent. Am Heart J 122 (1991), 1487–1489.
281. Kuck, K.H., Kunze, K.P., Schlüter, M., et al. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Am J Cardiol 62 (1988), 37L–44L.
282. Mamchur, S.E., Kurilin, M.Y., High-amplitude pace mapping increases safety of radiofrequency catheter ablation of parahisian ectopic foci. Pacing Clin Electrophysiol 35 (2012), 1458–1463.
283. Padanilam, B.J., Manfredi, J.A., Steinberg, L.A., et al. Differentiating junctional tachycardia and atrioventricular node re-entry tachycardia based on response to atrial extrastimulus pacing. J Am Coll Cardiol 52 (2008), 1711–1717.
284. Scheinman, M.M., Gonzalez, R.P., Cooper, M.W., et al. Clinical and electrophysiologic features and role of catheter ablation techniques in adult patients with automatic atrioventricular junctional tachycardia. Am J Cardiol 74 (1994), 565–572.
285. Fan, R., Tardos, J.G., Almasry, I., et al. Novel use of atrial overdrive pacing to rapidly differentiate junctional tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm 8 (2011), 840–844.
286. Srivathsan, K., Gami, A.S., Barrett, R., et al. Differentiating atrioventricular nodal reentrant tachycardia from junctional tachycardia: novel application of the delta H-A interval. J Cardiovasc Electrophysiol 19 (2008), 1–6.
287. Hamdan, M., Van Hare, G.F., Fisher, W., et al. Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol 78 (1996), 1292–1297.
288. Law, I.H., Von Bergen, N.H., Gingerich, J.C., et al. Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart. Heart Rhythm 3 (2006), 903–907.
289. Garson, A. Jr., Gillette, P.C., Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations. Am Heart J 102 (1981), 233–250.
290. Ko, J.K., Deal, B.J., Strasburger, J.F., et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69 (1992), 1028–1032.
291. Weindling, S.N., Saul, J.P., Walsh, E.P., Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 131 (1996), 66–72.
292. Garson, A. Jr., Gillette, P.C., McNamara, D.G., Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 98 (1981), 875–882.
293. Dixon, J., Foster, K., Wyllie, J., et al. Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child 90 (2005), 1190–1191.
294. Díaz-Parra, S., Sánchez-Yañez, P., Zabala-Argüelles, I., et al. Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department. Pediatr Emerg Care 30 (2014), 388–393.
295. Losek, J.D., Endom, E., Dietrich, A., et al. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med 33 (1999), 185–191.
296. Deal, B.J., Keane, J.F., Gillette, P.C., et al. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 5 (1985), 130–135.
297. Villain, E., Bonnet, D., Acar, P., et al. [Recommendations for the treatment of recurrent supraventricular tachycardia in infants]. Arch Pediatr 5 (1998), 133–138.
298. Fish, F.A., Gillette, P.C., Benson, D.W. Jr., Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 18 (1991), 356–365.
299. Lee, P.-C., Hwang, B., Chen, S.-A., et al. The results of radiofrequency catheter ablation of supraventricular tachycardia in children. Pacing Clin Electrophysiol 30 (2007), 655–661.
300. Van Hare, G.F., Javitz, H., Carmelli, D., et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 15 (2004), 759–770.
301. Aiyagari, R., Saarel, E.V., Etheridge, S.P., et al. Radiofrequency ablation for supraventricular tachycardia in children < or =15 kg is safe and effective. Pediatr Cardiol 26 (2005), 622–626.
302. Blaufox, A.D., Felix, G.L., Saul, J.P., Radiofrequency catheter ablation in infants
303. Blaufox, A.D., Paul, T., Saul, J.P., Radiofrequency catheter ablation in small children: relationship of complications to application dose. Pacing Clin Electrophysiol 27 (2004), 224–229.
304. Kantoch, M.J., Gulamhusein, S.S., Sanatani, S., Short- and long-term outcomes in children undergoing radiofrequency catheter ablation before their second birthday. Can J Cardiol 27 (2011), 523.e3–523.e9.
305. Schaffer, M.S., Gow, R.M., Moak, J.P., et al. Mortality following radiofrequency catheter ablation (from the Pediatric Radiofrequency Ablation Registry). Participating members of the Pediatric Electrophysiology Society. Am J Cardiol 86 (2000), 639–643.
306. Collins, K.K., Van Hare, G.F., Kertesz, N.J., et al. Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol 53 (2009), 690–697.
307. Batra, A.S., Chun, D.S., Johnson, T.R., et al. A prospective analysis of the incidence and risk factors associated with junctional ectopic tachycardia following surgery for congenital heart disease. Pediatr Cardiol 27 (2006), 51–55.
308. Andreasen, J.B., Johnsen, S.P., Ravn, H.B., Junctional ectopic tachycardia after surgery for congenital heart disease in children. Intensive Care Med 34 (2008), 895–902.
309. Haas, N.A., Camphausen, C.K., Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. J Thorac Cardiovasc Surg 136 (2008), 1215–1222.
310. Laird, W.P., Snyder, C.S., Kertesz, N.J., et al. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol 24 (2003), 133–137.
311. Kovacikova, L., Hakacova, N., Dobos, D., et al. Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. Ann Thorac Surg 88 (2009), 616–622.
312. Walsh, E.P., Saul, J.P., Sholler, G.F., et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 29 (1997), 1046–1053.
313. Sanatani, S., Potts, J.E., Reed, J.H., et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 5 (2012), 984–991.
314. van Engelen, A.D., Weijtens, O., Brenner, J.I., et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24 (1994), 1371–1375.
315. Bouchardy, J., Therrien, J., Pilote, L., et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 120 (2009), 1679–1686.
316. Bernier, M., Marelli, A.J., Pilote, L., et al. Atrial arrhythmias in adult patients with right- versus left-sided congenital heart disease anomalies. Am J Cardiol 106 (2010), 547–551.
317. Engelfriet, P., Boersma, E., Oechslin, E., et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 26 (2005), 2325–2333.
318. Trojnarska, O., Grajek, S., Kramer, L., et al. Risk factors of supraventricular arrhythmia in adults with congenital heart disease. Cardiol J 16 (2009), 218–226.
319. Verheugt, C.L., Uiterwaal, C.S.P.M., van der Velde, E.T., et al. Gender and outcome in adult congenital heart disease. Circulation 118 (2008), 26–32.
320. Akar, J.G., Kok, L.C., Haines, D.E., et al. Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol 38 (2001), 377–384.
321. Collins, K.K., Love, B.A., Walsh, E.P., et al. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol 86 (2000), 969–974.
322. de Groot, N.M.S., Zeppenfeld, K., Wijffels, M.C., et al. Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm 3 (2006), 526–535.
323. Koyak, Z., Kroon, B., de Groot, J.R., et al. Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 112 (2013), 1461–1467.
324. Mah, D.Y., Alexander, M.E., Cecchin, F., et al. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol 22 (2011), 1013–1017.
325. Wasmer, K., Köbe, J., Dechering, D.G., et al. Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair. Int J Cardiol 168 (2013), 2447–2452.
326. de Groot, N.M.S., Atary, J.Z., Blom, N.A., et al. Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences. Circ Arrhythm Electrophysiol 3 (2010), 148–154.
327. Hårdhammar, P.A., van Beusekom, H.M., Emanuelsson, H.U., et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93 (1996), 423–430.
328. Tanner, H., Lukac, P., Schwick, N., et al. Irrigated-tip catheter ablation of intraatrial reentrant tachycardia in patients late after surgery of congenital heart disease. Heart Rhythm 1 (2004), 268–275.
329. Triedman, J.K., Saul, J.P., Weindling, S.N., et al. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation 91 (1995), 707–714.
330. DeMazumder, D., Lake, D.E., Cheng, A., et al. Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias. Circ Arrhythm Electrophysiol 6 (2013), 555–561.
331. Yap, S.-C., Harris, L., Silversides, C.K., et al. Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery. J Am Coll Cardiol 56 (2010), 1589–1596.
332. Ammash, N.M., Phillips, S.D., Hodge, D.O., et al. Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. Int J Cardiol 154 (2012), 270–274.
333. Pass, R.H., Liberman, L., Al-Fayaddh, M., et al. Continuous intravenous diltiazem infusion for short-term ventricular rate control in children. Am J Cardiol 86 (2000), 559–562 A9.
334. Garnock-Jones, K.P., Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs 72 (2012), 109–132.
335. diMarco, J.P., Sellers, T.D., Lerman, B.B., et al. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 6 (1985), 417–425.
336. Haines, D.E., DiMarco, J.P., Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol 15 (1990), 1345–1354.
337. Kall, J.G., Kopp, D., Olshansky, B., et al. Adenosine-sensitive atrial tachycardia. Pacing Clin Electrophysiol 18 (1995), 300–306.
338. Olshansky, B., Okumura, K., Hess, P.G., et al. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol 11 (1988), 359–364.
339. Heisel, A., Jung, J., Stopp, M., et al. Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. Eur Heart J 18 (1997), 866–869.
340. Hoyer, A.W., Balaji, S., The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol 30 (2007), 1003–1008.
341. Crawford, W., Plumb, V.J., Epstein, A.E., et al. Prospective evaluation of transesophageal pacing for the interruption of atrial flutter. Am J Med 86 (1989), 663–667.
342. Rhodes, L.A., Walsh, E.P., Saul, J.P., Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J 130 (1995), 323–327.
343. Brockmeier, K., Ulmer, H.E., Hessling, G., Termination of atrial reentrant tachycardias by using transesophageal atrial pacing. J Electrocardiol 35:Suppl (2002), 159–163.
344. Stephenson, E.A., Casavant, D., Tuzi, J., et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 92 (2003), 871–876.
345. Rao, S.O., Boramanand, N.K., Burton, D.A., et al. Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. Int J Cardiol 136 (2009), 253–257.
346. Wells, R., Khairy, P., Harris, L., et al. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol 32 (2009), 1313–1318.
347. Warnes, C.A., Williams, R.G., Bashore, T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52 (2008), e143–e263.
348. Khairy, P., Van Hare, G.F., Balaji, S., et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 11 (2014), e102–e165.
349. Huang, C.J., Chiu, I.S., Lin, F.Y., et al. Role of electrophysiological studies and arrhythmia intervention in repairing Ebstein's anomaly. Thorac Cardiovasc Surg 48 (2000), 347–350.
350. Reich, J.D., Auld, D., Hulse, E., et al. The Pediatric Radiofrequency Ablation Registry's experience with Ebstein's anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol 9 (1998), 1370–1377.
351. Cappato, R., Schlüter, M., Weiss, C., et al. Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly. Circulation 94 (1996), 376–383.
352. Misaki, T., Watanabe, G., Iwa, T., et al. Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein's anomaly. J Thorac Cardiovasc Surg 110 (1995), 1702–1707.
353. Khositseth, A., Danielson, G.K., Dearani, J.A., et al. Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg 128 (2004), 826–833.
354. Bockeria, L., Golukhova, E., Dadasheva, M., et al. Advantages and disadvantages of one-stage and two-stage surgery for arrhythmias and Ebstein's anomaly. Eur J Cardiothorac Surg 28 (2005), 536–540.
355. Pressley, J.C., Wharton, J.M., Tang, A.S., et al. Effect of Ebstein's anomaly on short- and long-term outcome of surgically treated patients with Wolff-Parkinson-White syndrome. Circulation 86 (1992), 1147–1155.
356. Khairy, P., Harris, L., Landzberg, M.J., et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1 (2008), 250–257.
357. Lukac, P., Pedersen, A.K., Mortensen, P.T., et al. Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?. Heart Rhythm 2 (2005), 64–72.
358. Yap, S.-C., Harris, L., Downar, E., et al. Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery. J Cardiovasc Electrophysiol 23 (2012), 339–345.
359. Wu, J., Deisenhofer, I., Ammar, S., et al. Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace 15 (2013), 886–891.
360. Jones, D.G., Jarman, J.W.E., Lyne, J.C., et al. The safety and efficacy of trans-baffle puncture to enable catheter ablation of atrial tachycardias following the Mustard procedure: a single centre experience and literature review. Int J Cardiol 168 (2013), 1115–1120.
361. Scaglione, M., Caponi, D., Ebrille, E., et al. Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect. Europace, 2014, 1800–1807.
362. Giamberti, A., Chessa, M., Abella, R., et al. Surgical treatment of arrhythmias in adults with congenital heart defects. Int J Cardiol 129 (2008), 37–41.
363. Stulak, J.M., Dearani, J.A., Puga, F.J., et al. Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann Thorac Surg 81 (2006), 1780–1784.
364. Mavroudis, C., Deal, B.J., Backer, C.L., et al. Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 86 (2008), 857–868.
365. Karamlou, T., Silber, I., Lao, R., et al. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg 81 (2006), 1786–1793.
366. Deal, B.J., Mavroudis, C., Backer, C.L., et al. Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation 106 (2002), 575–579.
367. Mavroudis, C., Backer, C.L., Deal, B.J., et al. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 122 (2001), 863–871.
368. Mavroudis, C., Deal, B.J., Backer, C.L., et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg 84 (2007), 1457–1465.
369. Aboulhosn, J., Williams, R., Shivkumar, K., et al. Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. Congenit Heart Dis 5 (2010), 430–434.
370. Said, S.M., Burkhart, H.M., Schaff, H.V., et al. Fontan conversion: identifying the high-risk patient. Ann Thorac Surg 97 (2014), 2115–2121.
371. Gutierrez, S.D., Earing, M.G., Singh, A.K., et al. Atrial tachyarrhythmias and the Cox-maze procedure in congenital heart disease. Congenit Heart Dis 8 (2013), 434–439.
372. Terada, T., Sakurai, H., Nonaka, T., et al. Surgical outcome of Fontan conversion and arrhythmia surgery: Need a pacemaker?. Asian Cardiovasc Thorac Ann 22 (2013), 682–686.
373. Theodoro, D.A., Danielson, G.K., Porter, C.J., et al. Right-sided maze procedure for right atrial arrhythmias in congenital heart disease. Ann Thorac Surg 65 (1998), 149–153.
374. Silka, M.J., Manwill, J.R., Kron, J., et al. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 65 (1990), 488–493.
375. Ragonese, P., Drago, F., Guccione, P., et al. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Pacing Clin Electrophysiol 20 (1997), 2917–2923.
376. Banchs, J.E., Baquero, G.A., Nickolaus, M.J., et al. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Congenit Heart Dis 9 (2014), 221–227.
377. Tanel, R.E., Walsh, E.P., Lulu, J.A., et al. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J 130 (1995), 791–797.
378. Shotan, A., Ostrzega, E., Mehra, A., et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79 (1997), 1061–1064.
379. Tawam, M., Levine, J., Mendelson, M., et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 72 (1993), 838–840.
380. Ghosh, N., Luk, A., Derzko, C., et al. The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature. J Obstet Gynaecol Can 33 (2011), 17–23.
381. Allen, N.M., Page, R.L., Procainamide administration during pregnancy. Clin Pharm 12 (1993), 58–60.
382. Qasqas, S.A., McPherson, C., Frishman, W.H., et al. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 12 (2004), 201–221.
383. Bartalena, L., Bogazzi, F., Braverman, L.E., et al. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24 (2001), 116–130.
384. Jaeggi, E.T., Carvalho, J.S., De Groot, E., et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124 (2011), 1747–1754.
385. Ersbøll, A.S., Hedegaard, M., Søndergaard, L., et al. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG 121 (2014), 618–626.
386. Szumowski, L., Szufladowicz, E., Orczykowski, M., et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol 21 (2010), 877–882.
387. Damilakis, J., Theocharopoulos, N., Perisinakis, K., et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation 104 (2001), 893–897.
388. Chen, S.A., Lee, S.H., Wu, T.J., et al. Initial onset of accessory pathway-mediated and atrioventricular node reentrant tachycardia after age 65: clinical features, electrophysiologic characteristics, and possible facilitating factors. J Am Geriatr Soc 43 (1995), 1370–1377.
389. Chen, S.A., Chiang, C.E., Tai, C.T., et al. Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol 77 (1996), 41–46.
390. Zado, E.S., Callans, D.J., Gottlieb, C.D., et al. Efficacy and safety of catheter ablation in octogenarians. J Am Coll Cardiol 35 (2000), 458–462.
391. Rostock, T., Risius, T., Ventura, R., et al. Efficacy and safety of radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in the elderly. J Cardiovasc Electrophysiol 16 (2005), 608–610.
392. Kihel, J., Da Costa, A., Kihel, A., et al. Long-term efficacy and safety of radiofrequency ablation in elderly patients with atrioventricular nodal re-entrant tachycardia. Europace 8 (2006), 416–420.
393. Dagres, N., Piorkowski, C., Kottkamp, H., et al. Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome. Europace 9 (2007), 477–480.
394. Pedrinazzi, C., Durin, O., Agricola, P., et al. Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Card Electrophysiol 19 (2007), 179–185.
395. Hoffmann, B.A., Brachmann, J., Andresen, D., et al. Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry. Heart Rhythm 8 (2011), 981–987.
396. Yangni, N.O., Brembilla-Perrot, B., Clinical characteristics and management of paroxysmal junctional tachycardia in the elderly. Arch Cardiovasc Dis 101 (2008), 143–148.
397. Dewland, T.A., Glidden, D.V., Marcus, G.M., Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter. PLoS One, 9, 2014, e100509.